Product category:
Marketing + PR services
News Release from: Frost and Sullivan | Subject: Biopharmaceutical Manufacturing
Edited by the Processingtalk Editorial
Team on 13 November 2003
Meet the Frost and Sullivan Biopharma
expert
This year's Fine Chemicals Conference will be taking place in the Crowne Plaza Hotel in Amsterdam on November 25 and 26, 2003, and focus on latest developments in the biopharma sector
This year's Fine Chemicals Conference will be taking place in the Crowne Plaza Hotel in Amsterdam on November 25 and 26, 2003, and focus on latest developments in the biopharma sector Organised by PCE and CNI, the event promises to be just as valuable and insightful as it has been in previous years
This article was originally published on Processingtalk on 18 Jan 2005 at 8.00am (UK)
Related stories
Cost-effective biopharmaceutical manufacturing
Using live plants as factories holds massive potential for cost-effective biopharmaceutical manufacturing, and the unofficial moratorium on transgenic crops in Europe is beginning to wain
The HIV/AIDS Therapies Market
While antiretroviral drugs in existing categories continue to be the mainstay of the HIV/AIDS therapies market in the United States, the development of new drugs offers exciting growth prospects
The European breast cancer pharmaceuticals market
The quest for a breast cancer wonder drug, and improved survival rates, continue to pump up business in the breast cancer pharmaceutical industry
The Frost and Sullivan expert on biopharmaceutical manufacturing, Research Analyst Raju Adhikari, will also be among the speakers at the event.
On Wednesday, November 26, at 12.20 pm Mr Adhikari will debate the following question: "Will Demand exceed Supply for Biopharmaceutical Manufacturing".
Mr Adhikari has just finished extensive research into the rapidly progressing biopharmaceuticals market.
He will address the issue of supply and demand for manufacturing capacities, increasingly a cause of much speculation and considered to be a crucial issue that will make or break the industry progression.
In the short term, projected shortfall of supply in manufacturing capacities means companies are currently able to charge premium prices for providing this service but this could change entirely in the long run as new facilities and expansions could mean that manufacturers will face more difficult market conditions.
The Fine Chemicals Conference in Amsterdam is your chance to meet Mr Raju Adhikari to discuss these developments and to gain further insight into his research findings.
Don't miss it.
• Frost and Sullivan: contact details and other news
• Email this article to a colleague
• Register for the free Processingtalk email newsletter
• Processingtalk Home Page
Search the Pro-Talk network of sites
